{"filings":[{"id":1222078,"accession_number":"0001493152-26-029782","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-06-23T20:05:35+00:00","items":["7.01","9.01"],"status":"ready","headline":"AIxCrypto launches RoboShare robot rental marketplace and AIXC01 infrastructure at Automate 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Official launch of RoboShare, on-demand robot rental marketplace; goes live June 22 at RoboShare.com, starting in LA.","AIXC01 infrastructure network for autonomous assets provides Identity, Attestation, Access, and Settlement functions.","Robot Second Life Cycle strategy aims to maximize utilization, extended use value, and network value beyond first sale.","City Partner program invites local partners to operate RoboShare in new regions; pre-owned robot resale business in development.","Ground-air integration strategy extends framework to drones and low-altitude economy, leveraging RoboShare and AIXC01."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1111996,"accession_number":"0001493152-26-029096","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-06-17T20:30:26+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"AIxCrypto enters $50M common share purchase agreement with Gold King Arthur Holding","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement allows AIxCrypto to sell up to $50M in common shares to Gold King Arthur via VWAP purchases over 24 months.","Purchase price is 93% of lowest daily VWAP over three consecutive trading days; investor retains 3% draw fee per purchase.","Issuance limited to 19.99% of pre-deal voting power unless shareholder approval obtained.","Company paid $100,000 upfront fee; must seek shareholder approval within 45 days of closing.","Beneficial ownership capped at 9.99% for the investor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":724437,"accession_number":"0001493152-26-025670","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-05-28T21:23:37+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"AIxCrypto Holdings announces executive resignations, appointments, and wind-down of biotech segment","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Co-CEO Kevin Richardson II and director resigned effective May 21, 2026, with no disagreement disclosed.","CFO Koti Meka resigned as director immediately and as CFO effective June 20, 2026, citing no disagreement.","President Campbell Becher resigned effective May 21, 2026, with no disagreement reported.","Board appointed Jie (Jay) Sheng as President and CFO effective June 21, 2026, with $400k salary and equity awards.","Board approved discontinuation and wind-down of legacy biotechnology business segment, evaluating financial impact."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":443518,"accession_number":"0001493152-26-023124","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-05-14T20:31:14+00:00","items":["1.01","9.01"],"status":"ready","headline":"AIxCrypto sells Marizyme note package for $100K cash, royalty, and 4.99% equity in acquirer","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold secured promissory note (~$4.77M principal, 18% interest) and co-development note ($1.75M) from Marizyme to CABG Acquisition Corp.","Cash consideration $100K at closing; 10% royalty on cumulative net revenue over $20M, capped at $5.67M.","Seller receives 4.99% membership interest in new entity (CABG SPV) formed to acquire Marizyme assets; preemptive and registration rights included.","Closing subject to mutual agreement within 90 days; either party may terminate if not closed by then without further liability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":21761,"accession_number":"0001493152-26-022334","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-05-12T00:00:14+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"AIxCrypto pre-revenue in Q1; cash & digital assets $12.4M, $10M prepaid in Faraday","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Zero revenue; operating expenses $4.3M vs $2.7M a year ago, driven by higher G&A.","Cash and cash equivalents $6.2M; digital assets at fair value $6.2M; $10M prepaid investment in Faraday Future (FFAI).","Post-quarter expanded Faraday investment to $12.0M as proof-of-concept asset for RWA tokenization.","Operational: EAI data project with Faraday team set; Agentir AI arena reached internal review milestone.","Simplified capital structure: 15M common shares issued on Series B Preferred conversion."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.79,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":92958,"accession_number":"0001493152-26-017084","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-04-16T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"AIxCrypto amends investment agreement with GKA; expands FFAI scope, increases subscription to $12M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entrusted investment agreement amended to include FFAI preferred stock and debt instruments.","Securities purchase agreement amended: subscription amount increased to $12M; price set at $0.26.","True-up shares eliminated; replaced with 4-year warrant for 1M shares at $1.50, exercisable after 500th FX Super One delivery.","FFAI issued 1,926,337 common shares, 11,502 Series C Convertible Preferred shares, and warrant to GKA.","$2M loan from GKA to FFAI at 10% interest, terminated upon A&R purchase agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104221,"accession_number":"0001493152-26-013224","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"AIxCrypto reports FY2025 results: $19M cash, $10M crypto treasury, 5.8M registered wallets in AIxC Hub","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Completed $41M PIPE with Faraday Future (FFAI) as lead investor; rebranded from Qualigen to AIxCrypto in November 2025.","AIxC Hub launched in Jan 2026: 5,835,615 registered wallets and 1,392,427 daily active participants as of March 16, 2026.","Deployed $10M into FFAI stock for equity tokenization; established partnership with Pinnacle Real Estate for loan tokenization.","Total assets ~$31M, cash $19M, liabilities ~$3M; net cash used in operations $6.95M (2025) vs $6.33M (2024).","Path to profitability depends on 2026 revenue from EAI/RWA activities; targeting 100,000 MAU by year-end (excl. AIxC Hub)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104220,"accession_number":"0001493152-26-008328","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-02-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"AIxCrypto shifts focus to RWA and EAI, discontinues BesTrade and Digital Asset modules","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["AIxC Hub Season 2 launched with new Tenki-based features; rewards details next week.","X account reached 53,417 followers; engagement up 94%, impressions ~600,000.","Company to concentrate on Real-World Asset (RWA) and Embodied AI (EAI) strategy.","Discontinues BesTrade AI Agent and Digital Asset AI Management to improve capital discipline.","Co-CEO Jerry Wang outlines 2026 outlook focused on intelligent EV and AI robotics."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104219,"accession_number":"0001493152-26-007102","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-02-17T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"AIxCrypto hires Yueting Jia as Chief Advisor, formalizes Co-CEO and CFO employment agreements with equity incentives.","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Yueting Jia appointed Chief Advisor; $500K annual fee, $300K one-time engagement fee, plus annual RSU/PSU grants of $1.5M each.","Co-CEO Jiawei Wang gets $300K base salary, $200K cash advance vesting over 36 months, severance including 12-month base salary.","Co-CEO Kevin Richardson receives additional $4,500/month for pharmaceutical oversight; stay commitment through March 2026.","CFO Koti Meka (fractional, 20% time) gets $150K base, $70K bonus potential, $200K annual equity grants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104218,"accession_number":"0001493152-26-004774","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"AIxCrypto enters $10M FFAI investment, $100K/month consulting, Sei collaboration","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Consulting agreement with FF Global Partners for $100K/month plus up to $1M quarterly performance bonuses.","Entrusted $10M investment in Faraday Future (FFAI) shares via GKA; SPA closing subject to conditions.","Non-binding LOI with Aster Foundation to collaborate on Sei blockchain infrastructure.","Press release announces collaboration with Sei Dev Foundation for AI/blockchain on Sei Network, targeting Faraday Future ecosystem."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104217,"accession_number":"0001493152-26-000561","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2026-01-06T23:59:59+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"AIxCrypto enters non-binding term sheet to invest $10M in Faraday Future for tokenization strategy","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Non-binding term sheet to purchase $10M tranche of Faraday Future (NASDAQ: FFAI) common stock.","Shares intended as foundational asset for AIxCrypto's first tokenized equity product.","Represents strategic deployment of blockchain infrastructure toward tokenized RWA business launch.","Transaction facilitated by independent third party; binding agreement subject to approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120511,"accession_number":"0001493152-25-027824","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-12-16T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"AIxCrypto terminates auditor MGO, engages HTL as new independent accounting firm","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Audit Committee terminated Macias Gini & O’Connell LLP on December 12, 2025.","No disagreements or reportable events during the two most recent fiscal years or subsequent interim period.","Audit Committee approved engagement of HTL International, LLC as the new independent auditor on December 12, 2025.","No prior consultations with HTL on accounting principles, audit opinions, or disagreements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120510,"accession_number":"0001493152-25-024647","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-11-21T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Nasdaq cites AIxCrypto for failure to get shareholder nod on PIPE; now compliant but monitored","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["PIPE financing closed Sept 29, 2025 raised $41M; sold 337,432 common shares at $2.246 and 17,783 Series B preferred at $1,000/share.","Nasdaq Staff determined change of control occurred with new board and officer appointments, including Jiawei Wang (Co-CEO) and Koti Meka (CFO), both from Faraday Future.","Company subsequently obtained majority shareholder approval and Nasdaq confirmed compliance with Listing Rule 5635(b); matter closed.","Nov 19 notice confirms compliance with Equity Rule 5550(b)(1) but imposes a 1-year Panel Monitor; failure triggers a hearing requirement.","Company disputes that one board appointment was connected to the offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120509,"accession_number":"0001493152-25-024639","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-11-21T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"AIxCrypto (formerly Qualigen) rebrands to AI Web3; plans $5M tokenized FFAI stock purchase","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company renamed to AIxCrypto Holdings, Inc., trading under new ticker AIXC on Nasdaq.","Unveils 'Three Driving Forces' strategy: BesTrade DeAI Agent, RWA & EAI Ecosystem, AI-driven crypto asset mgmt.","First tokenized stock RWA project: $5M purchase of FFAI shares via third party to explore stock-token business.","YT Jia, Faraday Future founder, appointed Chief Advisor; Jerry Wang as Co-CEO.","Launches AIxC Labs for AI/Web3 investments; targeting 2-3 strategic investments by 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120508,"accession_number":"0001493152-25-024487","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-11-20T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"AIxCrypto appoints new Executive Director, Chairman, and Audit Committee member; two directors resign","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Koti Meka appointed Executive Director Nov 17, 2025; he also serves as CFO of the Company and Faraday Future.","Jie Sheng appointed Chairman of the Board; Sheng is Head of Operations & Finance Director of FF Global Partners.","Chad Chen appointed to Audit Committee; Chen is a partner at Yoka Smith and board member of Faraday Future.","Graydon Bensler and Braeden Lichti resigned as directors effective Nov 17, 2025; no disagreement cited.","No compensation arrangements were entered into with the newly appointed board members."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120514,"accession_number":"0001493152-25-023728","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["5.03","5.07","8.01","9.01"],"status":"ready","headline":"Qualigen shareholders approve all proposals; name change to AIxCrypto, Faraday Future becomes majority holder","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved private placement of 337,432 common shares and 39,943 Series B convertible preferred shares.","Faraday Future becomes majority owner with ~55% direct equity (incl. affiliates ~63%); will nominate majority of board.","Company rebrands to AIxCrypto Holdings, Inc., ticker changes to AIXC on Nov 20, 2025 from QLGN.","Company transitions from biotech to AI × Web3 platform, unveiling three-year roadmap at Nasdaq ceremony on Nov 20."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120513,"accession_number":"0001493152-25-017162","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-10-07T23:59:59+00:00","items":["4.01","5.02","9.01"],"status":"ready","headline":"Qualigen appoints new Co-CEO, CFO, three directors; auditor switches to MGO","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Withum resigned as auditor on Oct 1, 2025; MGO appointed Oct 3, 2025 for FY2025 audit and interim reviews.","Jiawei Wang (ex-Faraday Future president) appointed Co-CEO effective Oct 2; Koti Meka named CFO.","Board expanded: Kevin Chen (Sept 26), Chad Chen & Jie Sheng (Oct 2) appointed; Price, Lim, Becher resigned.","New directors fill audit, nominating, and compensation committees; Sheng chairs audit committee.","MGO also serves as auditor of Faraday Future; Wang and Meka both have Faraday Future ties."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120512,"accession_number":"0001493152-25-016923","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-10-03T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Qualigen closes $41M PIPE led by Faraday Future, pivots to crypto business as CXC10","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Faraday Future invested $30M for ~55% pro forma beneficial ownership; YT Jia invested $4M with 2-yr lockup.","Jerry Wang appointed Co-CEO; Koti Meka (FF CFO) appointed CFO; board cut to 5 with two FF designees.","Up to $6.8M for debt/operations; balance to fund crypto treasury; plans to rebrand as CXC10.","Series B convertible preferred issued at $1,000/share, convertible to common at $2.246, subject to shareholder approval by Oct 29.","Placement agent warrants issued for 6% of securities at $2.47 exercise price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137083,"accession_number":"0001493152-25-015846","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Qualigen Therapeutics appoints Kevin Chen as independent director effective Sept 26, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kevin Chen, 47, appointed as independent director, effective immediately.","Chen serves as Chief Economist and CIO of Horizon Financial.","He holds board seats at CurrenC Group, Australian Oilseeds Investments, Scage Future, Capitan Investment.","Former board member of Infint Acquisition Corporation; adjunct professor at NYU.","Chen holds PhD in Finance from University of Lausanne, and BA from Renmin University."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137082,"accession_number":"0001493152-25-014965","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-09-25T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Qualigen Therapeutics enters $41M PIPE led by Faraday Future; plans crypto pivot and rebrand","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Faraday Future leads $30M investment at $2.246/share for ~55% beneficial ownership; YT Jia personally invests $4M.","Total PIPE of $41M from FF, Jia, SIGN Foundation (backed by Binance Labs, Sequoia, etc.).","Upon approval, QLGN rebrands as CXC10, focusing on crypto/Web3; Jerry Wang named Co-CEO, Koti Meka CFO.","FF gets two board seats (potential to increase to four); board resignations; Jia appointed Chief Advisor.","Voting support agreements secured; closing expected ~Sept 29, 2025; placement agent Univest Securities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137081,"accession_number":"0001493152-25-013646","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-09-16T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Qualigen amends Marizyme promissory note, extends maturity to Aug 2026, adds $75k principal","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Maturity date corrected to August 21, 2026 (12-month term from August 2025).","Additional advance of $75,000 increases principal balance to $4,526,462.18.","Interest on additional advance accrues at the existing rate per the original note.","Security agreement reaffirmed; all obligations remain secured under existing terms.","No other modifications to the Amended and Restated Secured Demand Promissory Note."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137080,"accession_number":"0001641172-25-026864","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-09-08T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Qualigen gets final Nasdaq extension to prove equity compliance by Nov 15 after negative equity","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq Panel granted final exception to demonstrate compliance with $2.5M equity rule by Nov 15, 2025; no further extensions.","As of June 30, 2025, stockholders' equity was approximately negative $1.6 million, failing the requirement.","Company completed $4.3M Series A-3 Preferred private placement on July 28, but Panel excluded it from July 28 compliance date.","Amendment to Marizyme promissory note reduced collateral charge, increasing equity by over $600,000.","Company is current on SEC filings and regained compliance with Nasdaq Periodic Filing Rule."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137079,"accession_number":"0001641172-25-025702","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Qualigen restructures $4.45M Marizyme note, secures assets, pro forma equity positive","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amended Note principal $4,451,462 with 18% interest, due Aug 21, 2026; includes $216K new advance.","Marizyme granted security interest in substantially all assets under new Security Agreement.","Pro forma balance sheet shows cash $4.59M, total equity $3.24M; company reports equity > $2.5M.","Forbearance on demand for 365 days; default rate increases 5% per annum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137078,"accession_number":"0001641172-25-021198","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"Qualigen receives Nasdaq delisting notice but regains compliance with $4.5M preferred stock placement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on July 23, 2025 for failing to meet $2.5M stockholders' equity requirement.","Closed $4.5M private placement of Series A-3 Preferred Stock to regain equity compliance.","Nasdaq granted extension; company's compliance plan accepted for next 12 months.","Company made timely filing of Q1 10-Q on July 21, 2025.","No assurance of continued listing; company remains at risk."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137077,"accession_number":"0001641172-25-021174","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["1.01","5.03","3.02","7.01","8.01","9.01"],"status":"ready","headline":"Qualigen closes $4.5M private placement of Series A-3 Preferred; conversion price $2.80","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 4,500 Series A-3 Preferred shares at $1,000 each for $4.5M gross proceeds.","Initial conversion price $2.80 per share; convertible into 1,607,143 common shares.","Net proceeds to be used for working capital; up to $500k for investor relations.","Automatic reduction of Series A-2 conversion price from $3.64 to $2.80 triggered.","Company to file S-1 registration statement for resale of underlying shares within 45 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137076,"accession_number":"0001641172-25-019844","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-07-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Qualigen granted patents for QN-302 covering 25 countries through 2040","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Patents for QN-302 granted in over 20 European countries plus India, China, and Russia.","Patent titled 'Substituted Naphthalene Diimides and Their Use' covers product and manufacturing methods.","Expiration extends to 2040; drug targets pancreatic and gastrointestinal cancers.","Qualigen licensed QN-302 from University College of London (Prof. Stephen Neidle).","CEO states patent coverage strengthens position as drug development company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154359,"accession_number":"0001641172-25-016253","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-06-24T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Qualigen Therapeutics appoints Robert B. Lim as Audit Committee Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert B. Lim appointed Chair of Audit Committee effective June 20, 2025, replacing Graydon Bensler.","Bensler remains on the Board and as a member of the Audit Committee.","Lim is qualified as independent under Nasdaq rules and as an audit committee financial expert.","No material interest or arrangement exists in connection with Lim's appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154358,"accession_number":"0001641172-25-011530","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"Qualigen receives Nasdaq deficiency notice for late Q1 10-Q; delisting hearing set","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Qualigen on May 19, 2025 of failure to timely file Form 10-Q for quarter ended March 31, 2025.","Deficiency under Listing Rule 5250(c)(1) will be considered by the Hearings Panel as additional delisting basis.","Company has a previously scheduled hearing and intends to present its compliance plan.","No assurance that the Panel will grant an extension or that Qualigen will ultimately regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154357,"accession_number":"0001641172-25-008110","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"Qualigen gets Nasdaq delisting notice for late 10-K; faces suspension May 5 if no appeal","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received April 24 notice of non-compliance with Nasdaq Listing Rule 5250(c) due to delayed 2024 Form 10-K.","Under a December 2024 Panel Monitor, failure to maintain compliance triggers delisting; must appeal by May 1, 2025.","If no appeal, trading suspended at start of business on May 5, 2025; Nasdaq will file Form 25-NSE.","Company intends to appeal and file 10-K as soon as possible, but no assurances of extension or regaining compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":172942,"accession_number":"0001493152-25-003982","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2025-01-28T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Qualigen leads NanoSynex bridge round for rapid AST technology","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Qualigen is first investor in NanoSynex's 2025 bridge round of up to $500K.","NanoSynex's AST halves test time; global market projected at $4.7B by 2027.","US AST market expected $1.6B; NanoSynex targets EU approval 2027, US 2028.","NanoSynex holds 4 patents; product has competitive advantages and pipeline.","CEO says investment supports better antibiotic use and robust diagnostics."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189963,"accession_number":"0001493152-24-052099","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-12-26T23:59:59+00:00","items":["3.03","9.01"],"status":"ready","headline":"Qualigen amends Series A-2 Preferred to require shareholder vote on conversion price adjustments","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Filed Amended and Restated Certificate of Designation for Series A-2 Preferred Stock on Dec 23, 2024.","Amendment prohibits Conversion Price adjustments without majority shareholder approval per Nasdaq Rule 5635(d).","Approved by Board and holders of at least 67% of outstanding Series A-2 Preferred Stock.","Effective immediately upon filing with Delaware Secretary of State."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189962,"accession_number":"0001493152-24-047143","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-11-21T23:59:59+00:00","items":["1.01","3.02","3.03","8.01","9.01"],"status":"ready","headline":"Qualigen raises $5.1M in Series A-2 Preferred private placement; exchanges $1.1M notes","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 5,100 shares of Series A-2 Preferred at $1,000/share for $5.1M aggregate proceeds.","Conversion of preferred into common at $3.64/sh initially, subject to ratchet antidilution and 4.99% beneficial ownership cap.","Entered exchange agreement with Yi Hua Chen, converting $1.1M principal notes into 1,154 Series A-2 Preferred shares.","$800,000 of proceeds to be paid to IR Agency LLC for investor relations services per consulting agreement.","Company reports equity above $2.5M after the transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189955,"accession_number":"0001493152-24-047189","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K/A","filed_at":"2024-11-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Qualigen Therapeutics appoints Graydon Bensler as independent director and audit committee chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bensler appointed to Board effective Nov 7, 2024; named audit committee chair on Nov 21.","Director Agreement provides $5,000 monthly base fee plus eligibility for equity awards and indemnification.","Bensler is independent under Nasdaq rules; amendment corrects prior 8-K with proper agreement.","Appointment fills Board vacancy and strengthens audit committee oversight."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189961,"accession_number":"0001493152-24-045184","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Qualigen appoints Graydon Bensler as independent director effective Nov 7","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Graydon Bensler as independent board member effective November 7, 2024.","Bensler is a CFA with over 7 years experience in financial consulting and public company management.","Bensler will receive $2,500 per month base fee, subject to board re-evaluation after financing rounds.","Bensler co-founded an Ed Tech curriculum company and previously served as director of Health Logic Interactive Inc."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189960,"accession_number":"0001493152-24-044346","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-11-08T23:59:59+00:00","items":["3.03","8.01","5.03"],"status":"ready","headline":"Qualigen Therapeutics effects 1-for-50 reverse stock split to regain Nasdaq compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at 1:50 ratio effective 12:01 a.m. ET on November 5, 2024.","Reduces outstanding shares from ~36.8M to approx. 736k shares; no change in authorized shares.","No fractional shares; cash in lieu paid at $5.055 per pre-split share (closing price on Nov 4).","Intended to meet Nasdaq $1.00 minimum bid price requirement (Rule 5550(a)(2)).","Trading symbol remains QLGN; CUSIP changed to 74754R 301."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189959,"accession_number":"0001493152-24-043352","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-11-01T23:59:59+00:00","items":["5.03","7.01","9.01"],"status":"ready","headline":"Qualigen Therapeutics announces 1-for-50 reverse stock split to regain Nasdaq compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Effective Nov 5, 2024, at 12:01 a.m. ET; trading on split-adjusted basis from market open.","Reverse split ratio 1-for-50; reduces shares from ~36.7M to ~737k.","Approved by stockholders Oct 25, 2024; board set ratio same day.","Purpose: increase bid price to regain Nasdaq minimum bid price requirement.","Cash for fractional shares; no change in authorized shares or par value; new CUSIP 74754R 301."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189958,"accession_number":"0001493152-24-042874","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Qualigen Therapeutics Stockholders Approve Reverse Stock Split and Share Issuance to Alpha Capital at Annual Meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All five director nominees elected, each receiving over 14.3 million votes.","Ratification of WithumSmith+Brown as auditor approved with 17,030,627 votes in favor.","Reverse stock split (10:1 to 50:1) approved with 16,165,754 votes for, 1,435,884 against.","Issuance of >20% common stock to Alpha Capital Anstalt approved with 14,562,299 votes for, 347,563 against, 18,595 abstaining.","Advisory vote on executive compensation approved with 14,540,812 votes for, 297,422 against, 90,223 abstaining."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189957,"accession_number":"0001493152-24-042068","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-10-22T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Qualigen Therapeutics receives Nasdaq non-compliance notice for audit committee composition","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Notice received Oct 18, 2024, after director Matt Korenberg resigned from Board and Audit Committee effective Oct 3, 2024.","Audit Committee now has only two independent directors (Robert Lim, Cody Price); needs three per Nasdaq Rule 5605.","Cure period: earlier of next annual meeting or Oct 5, 2025; if meeting before Apr 1, 2025, compliance due by Apr 1, 2025.","Company plans to appoint one independent director to Audit Committee during the cure period.","No immediate effect on listing or trading of QLGN common stock on The Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":189956,"accession_number":"0001493152-24-040599","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-10-09T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Qualigen Therapeutics adds Braeden Lichti to board; Robert Lim named audit chair; Korenberg resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Matt Korenberg resigned director and audit chair Oct 3, 2024; no disagreement cited.","Braeden Lichti appointed independent director Oct 8, 2024; founder of BWL Investments and NorthStrive.","Robert Lim appointed as audit committee chairperson effective Oct 8, 2024.","Director agreement includes $5,000 monthly base fee, equity eligibility, and standard indemnification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206478,"accession_number":"0001493152-24-038351","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-09-26T23:59:59+00:00","items":["5.02","8.01"],"status":"ready","headline":"Qualigen CEO and CFO resign over disagreements; Board appoints interim CEO/CFO and President","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Michael Poirier (CEO/Chairman) and Christopher Lotz (CFO) resigned immediately on Sep 23, 2024, citing disagreements over company's future direction.","Board appointed Campbell Becher as President on Sep 25, 2024, effective immediately.","Board appointed Kevin Richardson II as Interim CEO and Interim CFO on Sep 26, 2024; consulting fee $4,500 per week.","Richardson previously served as CEO of Sanuwave Health, taking it from startup to $20M in revenue.","Audit, Compensation, and Nominating committees reconstituted: Korenberg (Audit chair), Price (Comp chair), Lim (Nominating chair)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206477,"accession_number":"0001493152-24-037600","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-09-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Qualigen Therapeutics receives Nasdaq extension to continue listing through November 19, 2024","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq Hearings Panel notice on Sept 11, 2024 granting extension for continued listing.","Must evidence compliance with all applicable Nasdaq criteria by November 19, 2024.","Company is diligently working to fulfill requirements for continued listing on Nasdaq."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206476,"accession_number":"0001493152-24-035508","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-09-09T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Qualigen closes $3.47M public offering of shares and warrants at $0.13","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 14,724,058 shares at $0.13/share plus pre-funded warrants for 11,972,754 shares at $0.129.","Gross proceeds ~$3.47M; net proceeds to repay $2M July Senior Note, fund clinical trials and working capital.","Directors and officers subject to 180-day lock-up on additional sales of securities.","Univest Securities acted as placement agent; received 3% cash fee and 5-year warrants for 800,904 shares at $0.156."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206475,"accession_number":"0001493152-24-035102","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-09-05T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Qualigen Therapeutics prices $3.46M public offering of common stock and pre-funded warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering: 14,724,058 shares at $0.13 each and pre-funded warrants for 11,972,754 shares at $0.129 per warrant.","Gross proceeds ~$3.46M; closing expected September 6, 2024.","Net proceeds to accelerate payment of $2M Senior Note from July 2024 and fund operations.","Also for clinical/preclinical studies, working capital, possible Marizyme expansion, and acquisitions.","Univest Securities acted as exclusive placement agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206474,"accession_number":"0001493152-24-030244","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Qualigen gets Nasdaq extension to Oct 31 to regain bid price and equity compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq Hearings Panel granted extension until October 31, 2024 to regain compliance.","Company non-compliant with Bid Price Rule (min $1.00) and Equity Rule (min $2.5M equity).","If unable to demonstrate compliance by Oct 31, 2024, securities may be delisted from Nasdaq.","CEO Michael S. Poirier signed the 8-K; hearing was held on July 16, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206473,"accession_number":"0001493152-24-028359","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-07-18T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Qualigen Therapeutics Advances $1.25 Million to Marizyme via Promissory Note at 18% Interest","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Qualigen advanced $1,250,000 to Marizyme, Inc. on July 15, 2024, under a demand promissory note dated July 12, 2024.","The note bears interest at 18% per annum and allows prepayment without premium or penalty.","The agreement is disclosed under Item 1.01 of Form 8-K filed July 18, 2024, signed by CEO Michael S. Poirier."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206472,"accession_number":"0001493152-24-027879","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-07-15T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Qualigen Therapeutics dismisses Baker Tilly, appoints Withum as new auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed Baker Tilly US, LLP effective July 11, 2024; engaged WithumSmith+Brown, PC as successor.","Baker Tilly's reports for FY 2022 and 2023 included a going concern explanatory paragraph.","No disagreements with Baker Tilly; a material weakness was communicated to the audit committee.","Company authorized Baker Tilly to respond fully to Withum's inquiries regarding the material weakness."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206471,"accession_number":"0001493152-24-027217","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-07-15T23:59:59+00:00","items":["1.01","5.02","2.03","5.01","8.01","9.01"],"status":"ready","headline":"Qualigen issues $2M senior note at 18%, replaces four directors","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $2M senior note to Corbo Capital Inc., due July 8, 2025, with 18% annual interest, unsecured, non-convertible.","Directors Richard David, Sidney Emery, Kurt Kruger, Ira Ritter resigned; Campbell Becher, Robert Lim, Cody Price appointed.","Warrant partially exercised; outstanding common shares now 12,155,830.","Note requires partial prepayments from percentage of future financings; principal and interest due at maturity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206470,"accession_number":"0001493152-24-027015","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-07-11T23:59:59+00:00","items":["1.01","5.02","5.01","8.01","9.01"],"status":"ready","headline":"Qualigen issues $2M senior note at 18% interest; board reshuffled; convertible debenture converted","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $2M senior note at 18% annual interest, matures July 8, 2025, with prepayment from future financings.","Richard David, Sidney Emery, Kurt Kruger, Ira Ritter resigned; Campbell Becher, Robert Lim, Cody Price appointed to board.","Holder of $3.3M 8% convertible debenture converted entire amount into common stock; 11,382,830 shares outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223627,"accession_number":"0001493152-24-021962","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-05-30T23:59:59+00:00","items":["3.01","8.01","9.01"],"status":"ready","headline":"Qualigen receives Nasdaq delisting notice for bid price, late filing, and equity shortfall","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Closing bid price below $1.00 for 30+ consecutive business days triggers non-compliance with Minimum Bid Price Requirement.","Failure to file Form 10-Q for period ended March 31, 2024 serves as additional delisting basis.","Company failed to meet $2.5M minimum stockholders' equity requirement by May 21, 2024 extension deadline.","Requested hearing on May 30, 2024; automatic 15-day stay; seeks extended stay pending hearing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223626,"accession_number":"0001493152-24-014821","cik":1460702,"company_name":"AIxCrypto Holdings, Inc.","ticker":"AIXC","form_type":"8-K","filed_at":"2024-04-16T23:59:59+00:00","items":["1.01","2.03","3.02","8.01","9.01"],"status":"ready","headline":"Qualigen issues $1.1M convertible debenture & enters $1.5M co-development with Marizyme for DuraGraft","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued $1.1M 8% convertible debenture and warrant to Yi Hua Chen upon exercise of Alpha option for $1M cash.","Entered co-development agreement with Marizyme to fund commercial launch of FDA-cleared DuraGraft for CABG surgery.","Qualigen to provide up to $1.5M funding; receives share of Marizyme's gross profit on US sales capped at 2x return.","Exclusivity period until May 31, 2024 to negotiate broader strategic relationship with Marizyme.","DuraGraft addresses >500,000 CABG procedures annually in US; Qualigen gains participation in revenue generation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":24889041.283464562,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-04-16T23:59:59+00:00|223626"}